Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no user-facing content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedThe government funding/operating status banner at the top of the page was removed.SummaryDifference0.3%

- Check43 days agoChange DetectedResults have been posted for the study (Results First Posted 2025-04-16) and the record shows updated dates, indicating completion and availability of outcome data.SummaryDifference0.4%

- Check50 days agoChange DetectedResults First Posted and Last Update are now labeled as '(Estimated)' dates, and the exact posting dates have been removed.SummaryDifference0.1%

- Check71 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.